Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2008-04-30
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Outcome of the study will be recommendations for the roadside selection procedure of drivers suspected of drug-related impairment. The recommendations will concentrate on the reliability of the selection procedure.
The study is part of an EU project DRUID. Two other countries in Europe take part to this study along with Finland.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening Protocol for the Evaluation of Research Participants
NCT01036217
Evaluation of an Interactive Mobile Phone-Based Brief Intervention to Reduce Substance-Impaired Driving
NCT05537116
Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose
NCT06855836
Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments
NCT01207791
Impaired Risk Awareness During Intoxication in DUI Offenders
NCT05247788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I
Drivers suspected of driving under the influence of drugs
On-site oral fluid screening devices
Comparison of screening device results to oral and/or blood sample results
Checklist: drug recognition expert
Correlation of drug recognition expert observations to findings for drugs in non-suspected/suspected cases
II
Drivers not suspected of driving under the influence of drugs
On-site oral fluid screening devices
Comparison of screening device results to oral and/or blood sample results
Checklist: drug recognition expert
Correlation of drug recognition expert observations to findings for drugs in non-suspected/suspected cases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
On-site oral fluid screening devices
Comparison of screening device results to oral and/or blood sample results
Checklist: drug recognition expert
Correlation of drug recognition expert observations to findings for drugs in non-suspected/suspected cases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older
* Willing to participate
Exclusion Criteria
* Not willing to participate
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital District of Helsinki and Uusimaa
OTHER
European Commission
OTHER
Finnish Institute for Health and Welfare
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pirjo Lillsunde, Dr
Role: PRINCIPAL_INVESTIGATOR
National Public Health Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Public Health Institute
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KTL 402-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.